Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1 β Production

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Tozsér, József ^a   Benko, Szilvia ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE EMODIN; ALOE VERA EXTRACT; CATHEPSIN B; CRYOPYRIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; GENIPIN; GINSENG EXTRACT; GINSENOSIDE; INFLAMMASOME; INTERLEUKIN 1BETA; MANGIFERIN; NATURAL PRODUCT; PROPOLIS; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SULFORAPHANE;

ALLERGIC REACTION; ALOE VERA; ALZHEIMER DISEASE; ASBESTOSIS; AUTOPHAGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME RELEASE; FIBROSIS; GINSENG; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; ION CURRENT; LUNG DISEASE; LYSOSOME; MEDICINAL PLANT; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SILICOSIS;

EID: 84988697112     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/5460302     Document Type: Review

References (127)

1. L. I. Romero, D.-N. Zhang, G. S. Herron, and M. A. Karasek, "Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells," Journal of Cellular Physiology, vol. 173, no. 1, pp. 84-92, 1997
2. G. Meng, F. Zhang, I. Fuss, A. Kitani, and W. Strober, "A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiatesTh17 cell-dominant immune responses," Immunity, vol. 30, no. 6, pp. 860-874, 2009
3. D. Lasigliè, E. Traggiai, S. Federici et al. , "Role of IL-1 beta in the development of human TH17 cells: lesson fromNLPR3mutated patients," PLoS ONE, vol. 6, no. 5,Article ID e20014, 2011
4. H. Schneider, F. Pitossi, D. Balschun, A. Wagner, A. Del Rey, and H. O. Besedovsky, "A neuromodulatory role of interleukin-1 in the hippocampus," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7778-7783, 1998
5. E. Gabay, G. Wolf, Y. Shavit, R. Yirmiya, and M. Tal, "Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury," European Journal of Pain, vol. 15, no. 3, pp. 242-248, 2011
6. A. del Rey, A. V. Apkarian, M. Martina, and H. O. Besedovsky, "Chronic neuropathic pain-like behavior and brain-borne IL-1," Annals of the New York Academy of Sciences, vol. 1262, no. 1, pp. 101-107, 2012
7. R. Yirmiya and I. Goshen, "Immune modulation of learning, memory, neural plasticity and neurogenesis," Brain, Behavior, and Immunity, vol. 25, no. 2, pp. 181-213, 2011
8. M. R. de Zoete, N. W. Palm, S. Zhu, and R. A. Flavell, "Inflammasomes," Cold Spring Harbor Perspectives in Biology, vol. 6, no. 12, Article ID a016287, 2014
9. M. Dagenais, A. Skeldon, and M. Saleh, "The inflammasome: in memory of Dr. Jurg Tschopp," Cell Death and Differentiation, vol. 19, no. 1, pp. 5-12, 2012
10. T.-D. Kanneganti,N. Özören,M. Body-Malapel et al. , "Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3," Nature, vol. 440, no. 7081, pp. 233-236, 2006
11. S. Mariathasan, D. S. Weiss, K. Newton et al. , "Cryopyrin activates the inflammasome in response to toxins and ATP," Nature, vol. 440, no. 7081, pp. 228-232, 2006
12. A. G. Hise, J. Tomalka, S. Ganesan et al. , "An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen candida albicans," Cell Host and Microbe, vol. 5, no. 5, pp. 487-497, 2009
13. M. T. Shio, S. C. Eisenbarth, M. Savaria et al. , "Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases," PLoS Pathogens, vol. 5, no. 8, article e1000559, 2009
14. F. Martinon, V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp, "Gout-associated uric acid crystals activate the NALP3 inflammasome," Nature, vol. 440, no. 7081, pp. 237-241, 2006
15. J. Tschopp and K. Schroder, "NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production" Nature Reviews Immunology, vol. 10, no. 3, pp. 210-215, 2010
16. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, "Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica," Science, vol. 320, no. 5876, pp. 674-677, 2008
17. A. Halle, V. Hornung, G. C. Petzold et al. , "The NALP3 inflammasome is involved in the innate immune response to amyloid-,"Nature Immunology, vol. 9, no. 8,pp. 857-865, 2008
18. B. Pazár, H.-K. Ea, S. Narayan et al. , "Basic calcium phosphate crystals induce monocyte/macrophage IL-1 secretion through theNLRP3 inflammasome in vitro," Journal of Immunology, vol. 186, no. 4, pp. 2495-2502, 2011
19. P. Duewell,H. Kono, K. J. Rayner et al. , "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals," Nature, vol. 464, no. 7293, pp. 1357-1361, 2010
20. S. Benko, D. J. Philpott, and S. E. Girardin, "The microbial and danger signals that activate Nod-like receptors," Cytokine, vol. 43, no. 3, pp. 368-373, 2008
21. F. G. Bauernfeind, G. Horvath, A. Stutz et al. , "Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression," Journal of Immunology, vol. 183, no. 2, pp. 787-791, 2009
22. M. G. Ghonime, O. R. Shamaa, S. Das et al. , "Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function," Journal of Immunology, vol. 192, no. 8, pp. 3881-3888, 2014
23. Q. He, H. You, X.-M. Li, T.-H. Liu, P. Wang, and B.-E. Wang, "HMGB1 promotes the synthesis of pro-il-1 and pro-il-18 by activation of p38 MAPK and NF-kB through receptors for advanced glycation end-products in macrophages," Asian Pacific Journal of Cancer Prevention, vol. 13,no. 4, pp. 1365-1370, 2012
24. C. Jin and R. A. Flavell, "Molecular mechanism of NLRP3 inflammasome activation," Journal of Clinical Immunology, vol. 30, no. 5, pp. 628-631, 2010
25. S. M. Man and T.-D. Kanneganti, "Regulation of inflammasome activation," Immunological Reviews, vol. 265, no. 1, pp. 6-21, 2015
26. K. Shimada, T. R. Crother, J. Karlin et al. , "Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis," Immunity, vol. 36, no. 3, pp. 401-414, 2012
27. G.-S. Lee, N. Subramanian, A. I. Kim et al. , "The calciumsensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP," Nature, vol. 491, no. 7427, pp. 123-127, 2012
28. A. J. Greaney, S. H. Leppla, and M. Moayeri, "Bacterial exotoxins and the inflammasome," Frontiers in Immunology, vol. 6, article 570, 2015
29. E. I. Elliott and F. S. Sutterwala, "Initiation and perpetuation of NLRP3 inflammasome activation and assembly," Immunological Reviews, vol. 265, no. 1, pp. 35-52, 2015
30. A. Sokolovska, C. E. Becker, W. K. E. Ip et al. , "Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPHoxidaseNOX2 to control phagosome function," Nature Immunology, vol. 14, no. 6, pp. 543-553, 2013
31. S. Kim, Y. Joe, S. O. Jeong et al. , "Endoplasmic reticulum stress is sufficient for the induction of IL-1 production via activation of the NF-κB and inflammasome pathways," Innate Immunity, vol. 20, no. 8, pp. 799-815, 2014
32. A. G. Lerner, J.-P. Upton, P. V. K. Praveen et al. , "IRE1 induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress," CellMetabolism, vol. 16, no. 2, pp. 250-264, 2012
33. S. Freigang, F. Ampenberger, G. Spohn et al. , "Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis," European Journal of Immunology, vol. 41, no. 7, pp. 2040-2051, 2011
34. G. M. Tannahill and L. A. J. O'Neill, "The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3," FEBS Letters, vol. 585, no. 11, pp. 1568-1572, 2011
35. M. Haneklaus and L. A. J. O'Neill, "NLRP3 at the interface of metabolism and inflammation," Immunological Reviews, vol. 265, no. 1, pp. 53-62, 2015
36. F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V. Hornung, "Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome," The Journal of Immunology, vol. 187, no. 2, pp. 613-617, 2011
37. D. Perregaux and C. A. Gabel, "Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity,"The Journal of Biological Chemistry, vol. 269, no. 21, pp. 15195-15203, 1994
38. J. M. Kahlenberg, K. C. Lundberg, S. B. Kertesy, Y. Qu, and G. R. Dubyak, "Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-κBdriven protein synthesis," Journal of Immunology, vol. 175, no. 11, pp. 7611-7622, 2005
39. R. Muñoz-Planillo, P. Kuffa, G. Martínez-Colón, B. Smith, T. Rajendiran, and G. Núñez, "K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulatematter," Immunity, vol. 38, no. 6, pp. 1142-1153, 2013
40. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp, "Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration," Cell Death and Differentiation, vol. 14, no. 9, pp. 1583-1589, 2007
41. T. Murakami, J. Ockinger, J. Yu et al. , "Critical role for calcium mobilization in activation of the NLRP3 inflammasome," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 28, pp. 11282-11287, 2012
42. V. Hornung, F. Bauernfeind, A. Halle et al. , "Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization," Nature Immunology, vol. 9, no. 8, pp. 847-856, 2008
43. J. Dan Dunn, L. A. J. Alvarez, X. Zhang, and T. Soldati, "Reactive oxygen species and mitochondria: a nexus of cellular homeostasis," Redox Biology, vol. 6, pp. 472-485, 2015
44. S. S. Iyer, Q. He, J. R. Janczy et al. , "Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation," Immunity, vol. 39, no. 2, pp. 311-323, 2013
45. X. Wang, W. Jiang, Y. Yan et al. , "RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway,"Nature Immunology, vol. 15,no. 12,pp. 1126-1133, 2014
46. T. Ichinohe, T. Yamazaki, T. Koshiba, and Y. Yanagi, "Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation afterRNAvirus infection," Proceedings of theNational Academy of Sciences of the United States of America, vol. 110, no. 44, pp. 17963-17968, 2013
47. N. Subramanian, K. Natarajan, M. R. Clatworthy, Z. Wang, and R. N. Germain, "The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation," Cell, vol. 153, no. 2, pp. 348-361, 2013
48. S. Y. Shaw, K. Tran, A. B. Castoreno et al. , "Selectivemodulation of autophagy, innate immunity, and adaptive immunity by small molecules," ACS Chemical Biology, vol. 8, no. 12, pp. 2724-2733, 2013
49. K. Nakahira, J. A. Haspel, V. A. K. Rathinam et al. , "Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome," Nature Immunology, vol. 12, no. 3, pp. 222-230, 2011
50. T. Misawa, M. Takahama, T. Kozaki et al. , "Microtubule-driven spatial arrangement ofmitochondria promotes activation of the NLRP3 inflammasome," Nature Immunology, vol. 14, no. 5, pp. 454-460, 2013
51. M. M. Budai, A. Varga, S. Milesz, J. Tozsér, and S. Benko, "Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages," Molecular Immunology, vol. 56, no. 4, pp. 471-479, 2013
52. J.-W. Han, D.-W. Shim, W.-Y. Shin et al. , "Anti-inflammatory effect of emodin via attenuation of NLRP3 inflammasome activation," International Journal of Molecular Sciences, vol. 16, no. 4, pp. 8102-8109, 2015
53. Y. Li, J. Li, S. Li et al. , "Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP/NLRP3 inflammasome activation in a manner dependent on AMPK," Toxicology and Applied Pharmacology, vol. 286, no. 1, pp. 53-63, 2015
54. Z. Gong, J. Zhou, H. Li et al. , "Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock," Molecular Nutrition and Food Research, vol. 59, no. 11, pp. 2132-2142, 2015
55. P.-Y. Tsai, S.-M. Ka, J.-M. Chang et al. , "Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation," Free Radical Biology and Medicine, vol. 51, no. 3, pp. 744-754, 2011
56. Z. Gao, Y. Han, Y. Hu et al. , "Targeting HO-1 by epigallocatechin-3-gallate reduces contrast-induced renal injury via anti-oxidative stress and anti-inflammation pathways," PLOS ONE, vol. 11, no. 2, article e0149032, 2016
57. V. Rajanbabu, L. Galam, J. Fukumoto et al. , "Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2," Cellular Immunology, vol. 297, no. 1, pp. 40-45, 2015
58. S.-X. Yu, C.-T. Du,W. Chen et al. , "Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression," Scientific Reports, vol. 5, article 17935, 2015
59. J. Kim, H. Ahn, B.-C. Han et al. , "Korean red ginseng extracts inhibit NLRP3 and AIM2 inflammasome activation," Immunology Letters, vol. 158, no. 1-2, pp. 143-150, 2014
60. S.-J. Yoon, J.-Y. Park, S. Choi et al. , "Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS," Biochemical and Biophysical Research Communications, vol. 463, no. 4, pp. 1184-1189, 2015
61. J. Song, J. Li, F. Hou, X. Wang, and B. Liu, "Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxininteracting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells," Metabolism, vol. 64, no. 3, pp. 428-437, 2015
62. C.-W. Pan, Z.-Z. Pan, J.-J. Hu et al. , "Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation," European Journal of Pharmacology, vol. 770, pp. 85-91, 2016
63. J. I. Hori,D. S. Zamboni,D. B. Carrão, G. H. Goldman, and A. A. Berretta, "The inhibition of inflammasome by Brazilian propolis (EPP-AF)," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 418508, 11 pages, 2013
64. C. Wang, Y. Pan, Q.-Y. Zhang, F.-M. Wang, and L.-D. Kong, "Quercetin and allopurinol ameliorate kidney injury in STZtreated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation," PLoS ONE, vol. 7, no. 6, Article ID e38285, 2012
65. Q.-H. Hu, X. Zhang, Y. Pan, Y.-C. Li, and L.-D. Kong, "Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats," Biochemical Pharmacology, vol. 84, no. 1, pp. 113-125, 2012
66. W. Wang, C. Wang,X.-Q. Ding et al. , "Quercetinandallopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats," British Journal of Pharmacology, vol. 169, no. 6, pp. 1352-1371, 2013
67. Q.-Y. Zhang, Y. Pan, R. Wang et al. , "Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats," Journal of Nutritional Biochemistry, vol. 25, no. 4, pp. 420-428, 2014
68. J. Wu, X. Xu, Y. Li et al. , "Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells," European Journal of Pharmacology, vol. 745, pp. 59-68, 2015
69. W. Jiang, Y. Huang, N. Han et al. , "Quercetin suppresses NLRP3 inflammasome activation and attenuates histopathology in a rat model of spinal cord injury," Spinal Cord, vol. 54, pp. 592-596, 2016
70. Y. Fu, Y. Wang, L. Du et al. , "Resveratrol inhibits ionising irradiation-induced inflammation in MSCs by activating Sirt1 and limiting NLRP-3 inflammasome activation," International Journal ofMolecular Sciences, vol. 14,no. 7, pp. 14105-14118, 2013
71. T.-T. Huang, H.-C. Lai, Y.-B. Chen et al. , "Cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages," Innate Immunity, vol. 20, no. 7, pp. 735-750, 2014
72. Y.-P. Chang, S.-M. Ka, W.-H. Hsu et al. , "Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy," Journal of Cellular Physiology, vol. 230, no. 7, pp. 1567-1579, 2015
73. S. J. Yang and Y. Lim, "Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation," Metabolism, vol. 63, no. 5, pp. 693-701, 2014
74. D.-M. Sui, Q. Xie, W.-J. Yi et al. , "Resveratrol protects against sepsis-associated encephalopathy and inhibits the NLRP3/IL-1 axis in microglia," Mediators of Inflammation, vol. 2016, Article ID 1045657, 10 pages, 2016
75. J. Wu, X. Li, G. Zhu, Y. Zhang, M. He, and J. Zhang, "The role of Resveratrol-inducedmitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered bymitochondrial ROS," Experimental Cell Research, vol. 341, no. 1, pp. 42-53, 2016
76. Y. W. An, K. A. Jhang, S. Y. Woo, J. L. Kang, and Y. H. Chong, "Sulforaphane exerts its anti-inflammatory effect against amyloid- peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages," Neurobiology of Aging, vol. 38, pp. 1-10, 2016
77. G. Yang, H. E. Lee, and J. Y. Lee, "A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet," Scientific Reports, vol. 6, Article ID24399, 2016
78. L. Franchi, R. Muñoz-Planillo, and G. Núñez, "Sensing and reacting to microbes through the inflammasomes," Nature Immunology, vol. 13, no. 4, pp. 325-332, 2012
79. S. L. Cassel and F. S. Sutterwala, "Sterile inflammatory responses mediated by the NLRP3 inflammasome," European Journal of Immunology, vol. 40, no. 3, pp. 607-611, 2010
80. M.-S. Tan, J.-T. Yu, T. Jiang, X.-C. Zhu, and L. Tan, "TheNLRP3 inflammasome in alzheimer's disease," Molecular Neurobiology, vol. 48, no. 3, pp. 875-882, 2013
81. M. Gold and J. El Khoury, "beta-amyloid, microglia, and the inflammasome in Alzheimer's disease," Seminars in Immunopathology, vol. 37, no. 6, pp. 607-611, 2015
82. P. M. Peeters, T. N. Perkins, E. F. M. Wouters, B. T. Mossman, and N. L. Reynaert, "Silica induces NLRP3 inflammasome activation in human lung epithelial cells," Particle and Fibre Toxicology, vol. 10, no. 1, article 3, 2013
83. H. Watanabe, O. Gaide, V. Pétrilli et al. , "Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity," Journal of Investigative Dermatology, vol. 127, no. 8, pp. 1956-1963, 2007
84. X. Dai, K. Sayama, M. Tohyama et al. , "Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes," Journal of Allergy and Clinical Immunology, vol. 127, no. 3, pp. 806-814, 2011
85. A. Varga, M. M. Budai, S. Milesz, A. Bácsi, J. Tözsér, and S. Benkö, "Ragweed pollen extract intensifies lipopolysaccharideinduced priming of NLRP3 inflammasome in human macrophages," Immunology, vol. 138, no. 4, pp. 392-401, 2013
86. B. Vandanmagsar, Y.-H. Youm, A. Ravussin et al. , "The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance," Nature Medicine, vol. 17, no. 2, pp. 179-189, 2011
87. H. Wen, D. Gris, Y. Lei et al. , "Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling," Nature Immunology, vol. 12, no. 5, pp. 408-415, 2011
88. L. Liang, X. Tan, Q. Zhou et al. , "IL-1 triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROSNLRP3 inflammasome-dependent pathways is involved in ocular behçet's disease," Investigative Ophthalmology and Visual Science, vol. 54, no. 1, pp. 402-414, 2013
89. S. Rosengren, H. M. Hoffman, W. Bugbee, and D. L. Boyle, "Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium," Annals of the Rheumatic Diseases, vol. 64, no. 5, pp. 708-714, 2005
90. J. M. Kahlenberg, "Anti-inflammatory panacea The expanding therapeutics of interleukin-1 blockade," Current Opinion in Rheumatology, vol. 28, no. 3, pp. 197-203, 2016
91. C.-H. Chien, M.-J. Lee, H.-C. Liou, H.-H. Liou, and W.-M. Fu, "Local immunosuppressive microenvironment enhances migration of melanoma cells to lungs in DJ-1 knockout mice," PLoS ONE, vol. 10, no. 2, Article ID e0115827, 2015
92. C. Antonopoulos and G. R. Dubyak, "Chemotherapy engages multiple pathways leading to IL-1 production by myeloid leukocytes," OncoImmunology, vol. 3, no. 1, Article ID e27499, 2014
93. E. Ozaki, M. Campbell, and S. L. Doyle, "Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives," Journal of Inflammation Research, vol. 8, pp. 15-27, 2015
94. J. H. Hamman, "Composition and applications of Aloe vera leaf gel," Molecules, vol. 13, no. 8, pp. 1599-1616, 2008
95. L. Langmead, R. J. Makins, and D. S. Rampton, "Antiinflammatory effects of aloe vera gel in human colorectal mucosa in vitro," Alimentary Pharmacology and Therapeutics, vol. 19, no. 5, pp. 521-527, 2004
96. N. Yun, C.-H. Lee, and S.-M. Lee, "Protective effect of Aloe vera on polymicrobial sepsis in mice," Food and Chemical Toxicology, vol. 47, no. 6, pp. 1341-1348, 2009
97. C. S. Yu, F. S. Yu, J. K. Chan et al. , "Aloe-emodin affects the levels of cytokines and functions of leukocytes from Sprague-Dawley rats," In Vivo, vol. 20, no. 4, pp. 505-509, 2006
98. M. Pulido-Moran, J. Moreno-Fernandez, C. Ramirez-Tortosa, and M. Ramirez-Tortosa, "Curcumin and health," Molecules, vol. 21, no. 3, article E264, 2016
99. Y.-F. Dong, L.-X. Wang, X. Huang et al. , "Kir6. 1 knockdown aggravates cerebral ischemia/reperfusion-induced neural injury in mice," CNS Neuroscience and Therapeutics, vol. 19, no. 8, pp. 617-624, 2013
100. P. J. Maier, K. Zemoura, M. A. Acuña, G. E. Yévenes, H. U. Zeilhofer, and D. Benke, "Ischemia-like oxygen and glucose deprivation mediates down-regulation of cell surface-aminobutyric acidB receptors via the endoplasmic reticulum (ER) stress-induced transcription factor CCAAT/enhancerbinding protein (C/EBP)-homologous protein (CHOP)," The Journal of Biological Chemistry, vol. 289, no. 18, pp. 12896-12907, 2014
101. H.-Y. Shin, S.-H. Kim, H.-J. Jeong et al. , "Epigallocatechin-3-gallate inhibits secretion of TNF-, IL-6 and IL-8 through the attenuation of ERK and NF-κB in HMC-1 cells," International Archives of Allergy and Immunology, vol. 142, no. 4, pp. 335-344, 2007
102. W. P. Pulskens, L. M. Butter, G. J. Teske et al. , "Nlrp3 prevents early renal interstitial edema and vascular permeability in unilateral ureteral obstruction," PLoS ONE, vol. 9, no. 1,Article ID e85775, 2014
103. S. Kamath and C. A. Roobottom, "Hyperdense pericardial effusion in dermatomyositis and contrast induced nephropathy," Emergency Radiology, vol. 11, no. 3, pp. 177-179, 2005
104. T. Akao, K. Kobashi, and M. Aburada, "Enzymic studies on the animal and intestinal bacterial metabolism of geniposide," Biological and Pharmaceutical Bulletin, vol. 17, no. 12, pp. 1573-1576, 1994
105. R. Wang, K. C. MoYung, M. H. Zhang, and K. Poon, "UCP2-and non-UCP2-mediated electric current in eukaryotic cells exhibits different properties," Environmental Science and Pollution Research, vol. 22, no. 24, pp. 19618-19631, 2015
106. J.-M. Lü, Q. Yao, and C. Chen, "Ginseng compounds: an update on their molecular mechanisms and medical applications," Current Vascular Pharmacology, vol. 7, no. 3, pp. 293-302, 2009
107. E. Hernandez-Cuellar, K. Tsuchiya, H. Hara et al. , "Cutting edge: nitric oxide inhibits the NLRP3 inflammasome," The Journal of Immunology, vol. 189, no. 11, pp. 5113-5117, 2012
108. B. B. Mishra, V. A. K. Rathinam, G. W. Martens et al. , "Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1," Nature Immunology, vol. 14, no. 1, pp. 52-60, 2013
109. T. Matsuno, S.-K. Jung, Y. Matsumoto, M. Saito, and J. Morikawa, "Preferential cytotoxicity to tumor cells of 3,5-diprenyl-4-hydroxycinnamic acid (artepillin C) isolated from propolis," Anticancer Research, vol. 17, no. 5A, pp. 3565-3568, 1997
110. X. Zhang, J.-H. Zhang, X.-Y. Chen et al. , "Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation," Antioxidants and Redox Signaling, vol. 22, no. 10, pp. 848-870, 2015
111. A. Zendedel, S. Johann, S. Mehrabi et al. , "Activation and regulation of NLRP3 inflammasome by intrathecal application of SDF-1a in a spinal cord injury model," Molecular Neurobiology, vol. 53, no. 5, pp. 3063-3075, 2016
112. H. Inoue and R. Nakata, "Resveratrol targets in inflammation," Endocrine,Metabolic and ImmuneDisorders-Drug Targets, vol. 15, no. 3, pp. 186-195, 2015
113. S. S. Kulkarni and C. Cantó, "The molecular targets of resveratrol," Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1852, no. 6, pp. 1114-1123, 2015
114. C. A. Houghton, R. G. Fassett, and J. S. Coombes, "Sulforaphane: translational research from laboratory bench to clinic," Nutrition Reviews, vol. 71, no. 11, pp. 709-726, 2013
115. A. T. Dinkova-Kostova, W. D. Holtzclaw, R. N. Cole et al. , "Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11908-11913, 2002
116. E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhäuser, "Nuclear factorB is a molecular target for sulforaphanemediated anti-inflammatory mechanisms," The Journal of Biological Chemistry, vol. 276, no. 34, pp. 32008-32015, 2001
117. A. Alfieri, S. Srivastava, R. C. M. Siow et al. , "Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke," Free Radical Biology and Medicine, vol. 65, pp. 1012-1022, 2013
118. C. Lee, G. H. Park, S.-R. Lee, and J.-H. Jang, "Attenuation of-amyloid-induced oxidative cell death by sulforaphane via activation of NF-E2-related factor 2," Oxidative Medicine and Cellular Longevity, vol. 2013,Article ID 313510, 12 pages, 2013
119. E. Barrajón-Catalán,M. Herranz-López, J. Joven et al. , "Molecular promiscuity of plant polyphenols in the management of age-related diseases: far beyond their antioxidant properties," Advances in Experimental Medicine and Biology, vol. 824, pp. 141-159, 2014
120. L. Bravo, "Polyphenols: chemistry, dietary sources,metabolism, and nutritional significance," Nutrition Reviews, vol. 56, no. 11, pp. 317-333, 1998
121. D. W. Lamming, J. G. Wood, and D. A. Sinclair, "Small molecules that regulate lifespan: evidence for xenohormesis," Molecular Microbiology, vol. 53, no. 4, pp. 1003-1009, 2004
122. K. T. Howitz and D. A. Sinclair, "Xenohormesis: sensing the chemical cues of other species," Cell, vol. 133, no. 3, pp. 387-391, 2008
123. P. L. Hooper, P. L. Hooper, M. Tytell, and L. Vgh, "Xenohormesis: health benefits from an eon of plant stress response evolution," Cell Stress and Chaperones, vol. 15,no. 6, pp. 761-770, 2010
124. B. L. Queen and T. O. Tollefsbol, "Polyphenols and aging," Current Aging Science, vol. 3, no. 1, pp. 34-42, 2010
125. J. A. Baur and D. A. Sinclair, "Therapeutic potential of resveratrol: the in vivo evidence," Nature Reviews Drug Discovery, vol. 5, no. 6, pp. 493-506, 2006
126. R. A. Sharma, A. J. Gescher, and W. P. Steward, "Curcumin: the story so far," European Journal of Cancer, vol. 41,no. 13,pp. 1955-1968, 2005
127. K. Milton, "Micronutrient intakes of wild primates: are humans different" Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol. 136, no. 1, pp. 47-59, 2003.